Results 121 to 130 of about 2,521,110 (208)

The effect of lysergic acid diethylamide (LSD) on whole-brain functional and effective connectivity. [PDF]

Neuropsychopharmacology, 2023
Bedford P, Hauke DJ, Wang Z, Roth V, Nagy-Huber M, Holze F, Ley L, Vizeli P, Liechti ME, Borgwardt S, Müller F, Diaconescu AO.   +11 more
europepmc   +1 more source

Effect of lysergic acid diethylamide (LSD) on reinforcement learning in humans. [PDF]

Psychol Med, 2023
Kanen JW, Luo Q, Rostami Kandroodi M, Cardinal RN, Robbins TW, Nutt DJ, Carhart-Harris RL, den Ouden HEM.   +7 more
europepmc   +1 more source

The effects of Lysergic Acid Diethylamide (LSD) on the Positive Valence Systems: A Research Domain Criteria (RDoC)-Informed Systematic Review. [PDF]

CNS Drugs, 2023
Pouyan N, Younesi Sisi F, Kargar A, Scheidegger M, McIntyre RS, Morrow JD.   +5 more
europepmc   +1 more source

Recent national trends in Salvia divinorum use and substance-use disorders among recent and former Salvia divinorum users compared with nonusers

Substance Abuse and Rehabilitation, 2011
Li-Tzy Wu1, George E Woody2, Chongming Yang3, Jih-Heng Li4, Dan G Blazer11Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, USA; 2Department of Psychiatry, University of Pennsylvania and Treatment Research ...
Blazer DG, Li JH, Yang C, Woody GE, Wu LT   +4 more
doaj  

Low doses of lysergic acid diethylamide (LSD) increase reward-related brain activity. [PDF]

Neuropsychopharmacology, 2023
Glazer J, Murray CH, Nusslock R, Lee R, de Wit H.   +4 more
europepmc   +1 more source

Systems-level analysis of local field potentials reveals differential effects of lysergic acid diethylamide and ketamine on neuronal activity and functional connectivity. [PDF]

Front Neurosci, 2023
Nasretdinov A, Barrientos SA, Brys I, Halje P, Petersson P.   +4 more
europepmc   +1 more source

Deconstruction of lysergic acid diethylamide. [PDF]

Proc Natl Acad Sci U S A
Basargin AG, Domokos A, Hennessey JJ, Aarrestad IK, Sambyal R, Khatib YA, Krüger J, Dunlap LE, Carter SJ, Rebek IA, McKee JL, Schalk SS, Liu M, Fettinger JC, Gonzalez MA, Potluri A, Tantillo DJ, Fiehn O, McCorvy JD, Olson DE.   +19 more
europepmc   +1 more source

Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants. [PDF]

Neuropsychopharmacology, 2023
Ley L, Holze F, Arikci D, Becker AM, Straumann I, Klaiber A, Coviello F, Dierbach S, Thomann J, Duthaler U, Luethi D, Varghese N, Eckert A, Liechti ME.   +13 more
europepmc   +1 more source

Adverse experiences resulting in emergency medical treatment seeking following the use of lysergic acid diethylamide (LSD). [PDF]

J Psychopharmacol, 2022
Kopra EI, Ferris JA, Rucker JJ, McClure B, Young AH, Copeland CS, Winstock AR.   +6 more
europepmc   +1 more source

Low-dose lysergic acid diethylamide alters subjective visual perception but not visual contrast surround suppression. [PDF]

Neurosci Conscious
Jaeckel LF, Logvinski D, Kanana M, Müller F, Rohner N, Becker AM, Liechti ME, Sterzer P.   +7 more
europepmc   +1 more source